In Tokyo, Modi pitches India's growth amid US tariff row

India is the fastest growing major economy and its political and economic stability as well as transparency in policies have made it an attractive investment destination, especially in areas of......

'Companies Will Be More Powerful Than Nations'

'If you align your ambition with India's rise, the peak of your careers will unfold alongside the peak of India's power. Businessman Gautam Adani's advice to students of IIT-Kharagpur. IMAGE:......

India's First Gene-Edited Sheep Unveiled

The edited sheep contains no foreign DNA, distinguishing it from transgenic organisms and paving the way for regulatory approval under India's evolving biotech policy framework. Kindly note the......

Siddaramaiah Flags Vaccine-Heart Link

Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a contributing factor to cardiac arrest deaths, citing several international......

Sensex rises 329 pts on rally in pharma, banking shares

Benchmark Sensex rose by nearly 329 points on Friday on strong gains in pharmaceutical and banking shares and foreign fund inflows. Photograph: Hemanshi Kamani/Reuters The 30-share BSE Sensex......

Mankind taps OpenAI to institutionalise AI in ops

Delhi-based pharma major Mankind Pharma on Wednesday announced a collaboration with OpenAI to institutionalise artificial intelligence (AI) across its value chain, making it one of the first few......

Pharma stocks slide as US headwinds hurt

Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US — their largest export market — have weighed heavily on investor sentiment this year. Photograph: Amit......

India's Space Manufacturing Boom

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033. IMAGE: Group Captain Shubhanshu Shukla during an experiment onboard the International......

Djokovic-owned biotech firm developing COVID treatment

IMAGE: The biotech firm, in which Novak Djokovic has an 80 per cent stake, has around 11 researchers working in Denmark, Australia and Slovenia, working on a treatment and not a vaccine according......